Cargando…
Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential
Cancer immunotherapy is fast rising as a prominent new pillar of cancer treatment, harnessing the immune system to fight against numerous types of cancer. Rho-kinase (ROCK) pathway is involved in diverse cellular activities, and is therefore the target of interest in various diseases at the cellular...
Autores principales: | Kim, Seohyun, Kim, Seong A., Han, Jihoon, Kim, In-San |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657458/ https://www.ncbi.nlm.nih.gov/pubmed/34884721 http://dx.doi.org/10.3390/ijms222312916 |
Ejemplares similares
-
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
por: Kim, Seohyun, et al.
Publicado: (2021) -
STING signaling is a potential immunotherapeutic target in colorectal cancer
por: Chon, Hong Jae, et al.
Publicado: (2019) -
Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
por: Wang, Jun, et al.
Publicado: (2023) -
Macrophages as a Potential Immunotherapeutic Target in Solid Cancers
por: Mishra, Alok K., et al.
Publicado: (2022) -
Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)